MHAT-Targovishte, AD

Targovishte 7700

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Psoriatic, Autism, Bipolar Depression, Bipolar Disorder, Bipolar I Depression, Depression, Depressive Disorder, Major, Lupus Erythematosus, Systemic, Schizophrenia

Studies at this site

• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis — Completed
• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age — Stopped early
• Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia — Stopped early
• Pediatric Open-Label Extension Study — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression — Completed
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed
• Lurasidone Pediatric Bipolar Study — Completed
• Pediatric Schizophrenia Efficacy and Safety Study — Completed